Refractory Follicular Lymphoma

Also known as: Refractory B-Cell Lymphoma / B-cell Lymphoma Refractory

DrugDrug NameDrug Description
DB00070HyaluronidaseHighly purified sheep hyaluronidase for administration by injection into the vitreous of the eye.
DB08935ObinutuzumabObinutuzumab is a humanized monoclonal antibody used as a combination treatment with chlorambucil to treat patients with untreated chronic lymphocytic leukemia. It was approved by the FDA in November 2013 and is marketed under the brand name Gazyva. There is a black box warning of fatal Hepatitis B Virus (HBV) reactivation and fatal Progressive Multifocal Leukoencephalopathy (PML).
DrugDrug NamePhaseStatusCount
DB05220Alisertib1Completed1
DB09052Blinatumomab1Recruiting1
DB09053Ibrutinib1Active Not Recruiting1
DB09053Ibrutinib1Recruiting2
DB05889Inotuzumab ozogamicin1Completed1
DB00480Lenalidomide1Active Not Recruiting1
DB00480Lenalidomide1Recruiting2
DB08935Obinutuzumab1Recruiting1
DB09037Pembrolizumab1Recruiting2
DB11759Pevonedistat1Recruiting1
DB06176Romidepsin1Completed1
DB06287Temsirolimus1Completed1
DB11581Venetoclax1Recruiting1
DB02546Vorinostat1Recruiting1
DB00262Carmustine1 / 2Not Yet Recruiting1
DB00262Carmustine1 / 2Recruiting1
DB00493Cefotaxime1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Recruiting1
DB00987Cytarabine1 / 2Not Yet Recruiting1
DB00987Cytarabine1 / 2Recruiting1
DB00773Etoposide1 / 2Not Yet Recruiting1
DB00773Etoposide1 / 2Recruiting1
DB00099Filgrastim1 / 2Not Yet Recruiting1
DB01073Fludarabine1 / 2Recruiting1
DB09053Ibrutinib1 / 2Recruiting2
DB00480Lenalidomide1 / 2Recruiting1
DB01042Melphalan1 / 2Not Yet Recruiting1
DB01042Melphalan1 / 2Recruiting1
DB06132Nivolumab1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB00073Rituximab1 / 2Not Yet Recruiting1
DB11942Selinexor1 / 2Recruiting1
DB11581Venetoclax1 / 2Recruiting2
DB01008Busulfan2Unknown Status1
DB00493Cefotaxime2Active Not Recruiting1
DB00493Cefotaxime2Recruiting1
DB00531Cyclophosphamide2Active Not Recruiting1
DB00531Cyclophosphamide2Recruiting1
DB00091Cyclosporine2Active Not Recruiting1
DB00091Cyclosporine2Unknown Status1
DB00997Doxorubicin2Recruiting1
DB01073Fludarabine2Active Not Recruiting1
DB01073Fludarabine2Unknown Status1
DB09053Ibrutinib2Active Not Recruiting1
DB09053Ibrutinib2Recruiting2
DB09054Idelalisib2Recruiting1
DB00480Lenalidomide2Recruiting1
DB00563Methotrexate2Unknown Status1
DB00688Mycophenolate mofetil2Active Not Recruiting1
DB08935Obinutuzumab2Recruiting1
DB09037Pembrolizumab2Recruiting2
DB00635Prednisone2Recruiting1
DB00073Rituximab2Recruiting1
DB04572Thiotepa2Unknown Status1
DB00541Vincristine2Recruiting1